See there’s your problem, you think anyone of this thread cares what you think....but the simple fact is Wheezo has FDA approval and Resappdx does not. Wheezo is being commercialised in the Western world, Resappdx desperately trying through Africa...Wheezo provides objective measurement , Resappdx does not and only indicates, Wheezo can be sold over the counter directly to the patient, Resappdx can not. Wheezo measures the primary symptom of asthma, Resappdx does not.
See there’s your problem, you think anyone of this thread cares...
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 140913 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.12pm 14/10/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable